A growing number of funding agencies now require that research articles they have funded must be made open access. This may be either by mandating deposit in repositories after an embargo period or by stipulating that research is published as open access.
Publishing in JPD complies with all major funding agency requirements.
From 2023 JPD is an Open Access Journal
From 2023 onwards JPD will be an open access journal, allowing authors the choice of two copyright licences: CC-BY-NC and CC-BY, thereby complying with all major funding mandates (you can read more about the copyright licenses here: https://creativecommons.org/about/cclicenses/). All papers published from 2023 onwards will be published in the gold open access model. All articles published as open access in JPD are automatically submitted to Pubmed Central by the publisher (there is a delay of 4-6 weeks after publication before articles are visible in Pubmed Central). The pre-2023 volume will remain as it is (part paywall, part open access)
Gold Open Access Publishing in JPD
Gold open access helps authors to comply with major funder mandates. Gold open access makes the article publicly available in the journal’s contents immediately upon publication. The publisher will also deposit the final, published version of the open access article into PubMed Central upon final publication. All open access articles are published under the terms of the Creative Commons Attribution Non-Commercial License 4.0.
The author will have the option to select the Creative Commons Attribution License (CC BY 4.0) copyright license for a surcharge. This license is required by certain funding agencies such as the Research Councils UK (RCUK) and Wellcome Trust.
Green Open Access Publishing in JPD for articles published pre-2023 (Self-Archiving)
Authors whose papers were published in the pre-2023 volume, who did not select open access publication, may self-archive and post the final manuscript version on their own institution, company or funding agency repositories without delay. Authors that are funded by the NIH, Research Councils UK (RCUK) and Wellcome Trust are welcome to deposit their final manuscript version to PubMed Central (Submission Method C) and Europe PubMed Central without delay. In all cases a publication reference and URL to the journal’s website must be provided on the first page of the manuscript.
JPD has no issue with authors submitting their article to a pre-print service such as BioRxiv or MedRxiv before acceptance in the journal. When submitting, do add a note clarifying that your article is available as a pre-print or in process of becoming a pre-print.